Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India

被引:0
|
作者
Saumya Srivastava
Jyotsna Mishra
Anil Kumar Gupta
Amit Singh
Prem Shankar
Sarman Singh
机构
[1] All India Institute of Medical Sciences,Division of Clinical Microbiology and Molecular Medicine, Department of Laboratory Medicine
来源
Parasites & Vectors | / 10卷
关键词
Visceral leishmaniasis; Miltefosine; Drug resistance; Bihar; Jharkhand;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] TWO CASES OF VISCERAL LEISHMANIASIS IN COLOMBIA RESISTANT TO MEGLUMINE ANTIMONIAL TREATMENT
    Dario Velez, Ivan
    Maria Colmenares, Lina
    Aguirre Munoz, Carlos
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2009, 51 (04): : 231 - 236
  • [22] Persistence of Leishmania donovani Antibodies in Past Visceral Leishmaniasis Cases in India
    Gidwani, Kamlesh
    Picado, Albert
    Ostyn, Bart
    Singh, Shri Prakash
    Kumar, Rajiv
    Khanal, Basudha
    Lejon, Veerle
    Chappuis, Francois
    Boelaert, Marleen
    Sundar, Shyam
    CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (02) : 346 - 348
  • [23] Quantitative PCR in Epidemiology for Early Detection of Visceral Leishmaniasis Cases in India
    Sudarshan, Medhavi
    Singh, Toolika
    Singh, Abhishek Kumar
    Chourasia, Ankita
    Singh, Bhawana
    Wilson, Mary E.
    Chakravarty, Jaya
    Sundar, Shyam
    PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (12):
  • [24] Miltefosine for Visceral and Cutaneous Leishmaniasis: Drug Characteristics and Evidence-Based Treatment Recommendations
    Monge-Maillo, Begona
    Lopez-Velez, Rogelio
    CLINICAL INFECTIOUS DISEASES, 2015, 60 (09) : 1398 - 1404
  • [25] Nanotized Curcumin and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis
    Tiwari, Brajendra
    Pahuja, Richa
    Kumar, Pradeep
    Rath, Srikanta Kumar
    Gupta, Kailash Chand
    Goyal, Neena
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (03)
  • [26] Two Cases of Visceral Leishmaniasis from Kahramanmaras, Turkey
    Karaoglan, Ilkay
    Eksi, Fahriye
    Sahin, Handan Haydaroglu
    Pehlivan, Mustafa
    Sahin, Sema Tekin
    Bosnak, Vuslat Kecik
    Bilici, Muhammed
    Namiduru, Mustafa
    Karsligil, Tekin
    MIKROBIYOLOJI BULTENI, 2015, 49 (02): : 295 - 298
  • [27] Genetic typing reveals monomorphism between antimony sensitive and resistant Leishmania donovani isolates from visceral leishmaniasis or post kala-azar dermal leishmaniasis cases in India
    B. V. Subba Raju
    Srividya Gurumurthy
    Katrin Kuhls
    Vasundhra Bhandari
    Gabriele Schnonian
    Poonam Salotra
    Parasitology Research, 2012, 111 : 1559 - 1568
  • [28] Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India
    Singh, Rudra Pratap
    Picado, Albert
    Alam, Shahnawaz
    Hasker, Epco
    Singh, Shri Prakash
    Ostyn, Bart
    Chappuis, Francois
    Sundar, Shyam
    Boelaert, Marleen
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 (11) : 1345 - 1348
  • [29] Efficacy of picroliv in combination with miltefosine, an orally effective antileishmanial drug against experimental visceral leishmaniasis
    Gupta, S
    Ramesh
    Sharma, SC
    Srivastava, VML
    ACTA TROPICA, 2005, 94 (01) : 41 - 47
  • [30] Targeted Oral Fixed-Dose Combination of Amphotericin B-Miltefosine for Visceral Leishmaniasis
    Fernandez-Garcia, Raquel
    Walsh, David
    O'Connell, Peter
    Passero, Luiz Felipe D.
    de Jesus, JessicaA.
    Laurenti, Marcia Dalastra
    Dea-Ayuela, Maria Auxiliadora
    Ballesteros, M. Paloma
    Lalatsa, Aikaterini
    Bolas-Fernandez, Francisco
    Healy, Anne Marie
    Serrano, Dolores R.
    MOLECULAR PHARMACEUTICS, 2025, 22 (03) : 1437 - 1448